{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:24:14Z","timestamp":1787286254501,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05833-5","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:08:18Z","timestamp":1787274498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative systems biology identifies PSMB2 as a core oxidative stress\u2013associated target in triple-negative breast cancer"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5827-6040","authenticated-orcid":false,"given":"Fahad M.","family":"Alshabrmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"5","key":"5833_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrc1361","volume":"4","author":"J Adams","year":"2004","unstructured":"Adams J (2004) The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4(5):349\u2013360","journal-title":"Nat Rev Cancer"},{"issue":"27","key":"5833_CR2","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1200\/JCO.2013.55.0491","volume":"32","author":"S Adams","year":"2014","unstructured":"Adams S et al (2014) Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol 32(27):2959\u20132966","journal-title":"J Clin Oncol"},{"issue":"1","key":"5833_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","volume":"41","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40\u201359","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"5833_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P et al (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807\u2013818","journal-title":"Mol Pharm"},{"key":"5833_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M et al (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15\u201323","journal-title":"Breast"},{"issue":"1","key":"5833_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10555-007-9049-z","volume":"26","author":"YG Assaraf","year":"2007","unstructured":"Assaraf YG (2007) Molecular basis of antifolate resistance. Cancer Metastasis Rev 26(1):153\u2013181","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"5833_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.31643\/2023\/6445.13","volume":"325","author":"KA Azzam","year":"2023","unstructured":"Azzam KA (2023) SwissADME and pkCSM webservers predictors: an integrated online platform for accurate and comprehensive predictions for in silico ADME\/T properties of artemisinin and its derivatives. Kompleksnoe Ispol\u02b9zovanie Mineral\u02b9nogo Syr\u02b9\u00e2\/complex Use of Mineral Resources\/mineraldik Shikisattardy Keshendi Paidalanu 325(2):14\u201321","journal-title":"Kompleksnoe Ispol\u02b9zovanie Mineral\u02b9nogo Syr\u02b9\u00e2\/complex Use of Mineral Resources\/mineraldik Shikisattardy Keshendi Paidalanu"},{"issue":"4","key":"5833_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/annonc\/mdy024","volume":"29","author":"Y Bareche","year":"2018","unstructured":"Bareche Y et al (2018) Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis. Ann Oncol 29(4):895\u2013902","journal-title":"Ann Oncol"},{"issue":"suppl_1","key":"5833_CR9","first-page":"D562","volume":"33","author":"T Barrett","year":"2005","unstructured":"Barrett T et al (2005) NCBI GEO: mining millions of expression profiles\u2014database and tools. Nucleic Acids Res 33(suppl_1):D562\u2013D566","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"5833_CR10","doi-asserted-by":"publisher","first-page":"1166S","DOI":"10.1093\/ajcn\/59.5.1166S","volume":"59","author":"C Beecher","year":"1994","unstructured":"Beecher C (1994) Cancer preventive properties of varieties of Brassica oleracea: a review. Am J Clin Nutr 59(5):1166S-1170S","journal-title":"Am J Clin Nutr"},{"issue":"16","key":"5833_CR11","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1002\/cam4.4095","volume":"10","author":"M Behring","year":"2021","unstructured":"Behring M et al (2021) Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent. Cancer Med 10(16):5712\u20135720","journal-title":"Cancer Med"},{"issue":"11","key":"5833_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G et al (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13(11):674\u2013690","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"5833_CR13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/cancers14051253","volume":"14","author":"M Bou Zerdan","year":"2022","unstructured":"Bou Zerdan M et al (2022) Triple negative breast cancer: updates on classification and treatment in 2021. Cancers (Basel) 14(5):1253","journal-title":"Cancers (Basel)"},{"key":"5833_CR14","doi-asserted-by":"publisher","first-page":"vi7","DOI":"10.1093\/annonc\/mds187","volume":"23","author":"P Boyle","year":"2012","unstructured":"Boyle P (2012) Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol 23:vi7\u2013vi12","journal-title":"Ann Oncol"},{"key":"5833_CR15","doi-asserted-by":"crossref","unstructured":"Burley SK et al (2017) Protein Data Bank (PDB): the single global macromolecular structure archive. Protein crystallography: methods and protocols, pp 627\u2013641","DOI":"10.1007\/978-1-4939-7000-1_26"},{"issue":"7","key":"5833_CR16","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","volume":"21","author":"MD Burstein","year":"2015","unstructured":"Burstein MD et al (2015) Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res 21(7):1688\u20131698","journal-title":"Clin Cancer Res"},{"issue":"10","key":"5833_CR17","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1111\/j.1582-4934.2009.00832.x","volume":"14","author":"JS Carew","year":"2010","unstructured":"Carew JS et al (2010) Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J Cell Mol Med 14(10):2448\u20132459","journal-title":"J Cell Mol Med"},{"issue":"1","key":"5833_CR18","first-page":"142","volume":"9","author":"EW Chan","year":"2019","unstructured":"Chan EW et al (2019) Role of scutellarin in human cancer\u2014a review. J Appl Pharm Sci 9(1):142\u2013146","journal-title":"J Appl Pharm Sci"},{"key":"5833_CR19","doi-asserted-by":"crossref","unstructured":"Chen B (2018) Profiling tumor infiltrating immune cells with CIBERSORT. Cancer systems biology: methods and protocols. Springer, pp 243\u2013259","DOI":"10.1007\/978-1-4939-7493-1_12"},{"issue":"Suppl 4","key":"5833_CR20","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H et al (2014) CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(Suppl 4):S11","journal-title":"BMC Syst Biol"},{"issue":"19","key":"5833_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/app14198948","volume":"14","author":"G-A Croitoru","year":"2024","unstructured":"Croitoru G-A et al (2024) Nanostructured drug delivery systems in immunotherapy: an updated overview of nanotechnology-based therapeutic innovations. Appl Sci (Basel) 14(19):8948","journal-title":"Appl Sci (Basel)"},{"issue":"22","key":"5833_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225694","volume":"13","author":"G Cserni","year":"2021","unstructured":"Cserni G et al (2021) Triple-negative breast cancer histological subtypes with a favourable prognosis. Cancers (Basel) 13(22):5694","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5833_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717","journal-title":"Sci Rep"},{"issue":"W1","key":"5833_CR24","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47(W1):W357\u2013W364","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5833_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert C et al (2018) Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol 19(1):40\u201350","journal-title":"Lancet Oncol"},{"key":"5833_CR26","unstructured":"Dimitriadou E et al (2006) The e1071 package. Misc functions of department of statistics (e1071), TU Wien, p 297"},{"issue":"1","key":"5833_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31674\/ijbb.2024.v01i01.001","volume":"1","author":"A Elengoe","year":"2024","unstructured":"Elengoe A (2024) A short review on breast cancer. Int J Biotechnol Biomed (IJBB) 1(1):1\u201311","journal-title":"Int J Biotechnol Biomed (IJBB)"},{"key":"5833_CR28","doi-asserted-by":"crossref","unstructured":"El-Hachem N (2017) AutoDock and AutoDockTools for protein-ligand docking: beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a case study. Neuroproteomics: methods and protocols. Springer, pp 391\u2013403","DOI":"10.1007\/978-1-4939-6952-4_20"},{"key":"5833_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.681476","volume":"11","author":"M Ensenyat-Mendez","year":"2021","unstructured":"Ensenyat-Mendez M et al (2021) Current triple-negative breast cancer subtypes: dissecting the most aggressive form of breast cancer. Front Oncol 11:681476","journal-title":"Front Oncol"},{"issue":"1","key":"5833_CR30","first-page":"64","volume":"1825","author":"S Frankland-Searby","year":"2012","unstructured":"Frankland-Searby S, Bhaumik SR (2012) The 26S proteasome complex: an attractive target for cancer therapy. Biochim Biophys Acta 1825(1):64\u201376","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"5833_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","volume":"14","author":"WH Fridman","year":"2017","unstructured":"Fridman WH et al (2017) The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol 14(12):717\u2013734","journal-title":"Nat Rev Clin Oncol"},{"key":"5833_CR32","doi-asserted-by":"publisher","first-page":"820806","DOI":"10.3389\/fphar.2022.820806","volume":"13","author":"S Fuloria","year":"2022","unstructured":"Fuloria S et al (2022) A comprehensive review on the therapeutic potential of Curcuma longa Linn. in relation to its major active constituent curcumin. Front Pharmacol 13:820806","journal-title":"Front Pharmacol"},{"key":"5833_CR33","doi-asserted-by":"crossref","unstructured":"Genuer R, Poggi J-M (2020) Random forests. Random forests with R. Springer, pp 33\u201355","DOI":"10.1007\/978-3-030-56485-8_3"},{"issue":"1","key":"5833_CR34","doi-asserted-by":"publisher","first-page":"13206","DOI":"10.1038\/s41598-020-69995-9","volume":"10","author":"I Greco","year":"2020","unstructured":"Greco I et al (2020) Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. Sci Rep 10(1):13206","journal-title":"Sci Rep"},{"issue":"19","key":"5833_CR35","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1073\/pnas.0903139106","volume":"106","author":"M Haberland","year":"2009","unstructured":"Haberland M et al (2009) Genetic dissection of histone deacetylase requirement in tumor cells. Proc Natl Acad Sci U S A 106(19):7751\u20137755","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5833_CR36","unstructured":"Hastie T, Qian J (2016) Glmnet vignette. Retrieved June 9,\u00a02014, pp 1\u201330"},{"issue":"1","key":"5833_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","volume":"27","author":"FM Howard","year":"2021","unstructured":"Howard FM, Olopade OI (2021) Epidemiology of triple-negative breast cancer: a review. Cancer J 27(1):8\u201316","journal-title":"Cancer J"},{"issue":"2","key":"5833_CR38","first-page":"135","volume":"14","author":"BL Jejurikar","year":"2021","unstructured":"Jejurikar BL, Rohane SH (2021) Drug designing in discovery studio. Asian J Res Chem 14(2):135\u2013138","journal-title":"Asian J Res Chem"},{"issue":"22","key":"5833_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cells12222628","volume":"12","author":"DY Kang","year":"2023","unstructured":"Kang DY et al (2023) Anticancer effects of 6-gingerol through downregulating iron transport and PD-L1 expression in non-small cell lung cancer cells. Cells 12(22):2628","journal-title":"Cells"},{"issue":"7","key":"5833_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072106","volume":"27","author":"MJ Kim","year":"2022","unstructured":"Kim MJ et al (2022) Reduced HIF-1\u03b1 stability induced by 6-gingerol inhibits lung cancer growth through the induction of cell death. Molecules 27(7):2106","journal-title":"Molecules"},{"issue":"D1","key":"5833_CR41","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S et al (2025) PubChem 2025 update. Nucleic Acids Res 53(D1):D1516\u2013D1525","journal-title":"Nucleic Acids Res"},{"key":"5833_CR42","doi-asserted-by":"publisher","DOI":"10.4137\/CIN.S14058","volume":"13","author":"SA Knaack","year":"2014","unstructured":"Knaack SA, Siahpirani AF, Roy S (2014) A pan-cancer modular regulatory network analysis to identify common and cancer-specific network components. Cancer Inform 13:CIN.S14058","journal-title":"Cancer Inform"},{"issue":"11","key":"5833_CR43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.tcb.2022.04.008","volume":"32","author":"L Kolmar","year":"2022","unstructured":"Kolmar L et al (2022) Technological and computational advances driving high-throughput oncology. Trends Cell Biol 32(11):947\u2013961","journal-title":"Trends Cell Biol"},{"issue":"2","key":"5833_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","volume":"293","author":"P Kumar","year":"2016","unstructured":"Kumar P, Aggarwal R (2016) An overview of triple-negative breast cancer. Arch Gynecol Obstet 293(2):247\u2013269","journal-title":"Arch Gynecol Obstet"},{"issue":"15","key":"5833_CR45","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1042\/CS20160935","volume":"131","author":"AB Kunnumakkara","year":"2017","unstructured":"Kunnumakkara AB et al (2017) Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin Sci 131(15):1781\u20131799","journal-title":"Clin Sci"},{"issue":"1","key":"5833_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9(1):559","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"5833_CR47","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD et al (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121(7):2750\u20132767","journal-title":"J Clin Invest"},{"issue":"6","key":"5833_CR48","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1109\/TCBB.2020.2973148","volume":"18","author":"X Li","year":"2020","unstructured":"Li X et al (2020) FUNMarker: fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers. IEEE ACM Trans Comput Biol Bioinform 18(6):2483\u20132491","journal-title":"IEEE ACM Trans Comput Biol Bioinform"},{"key":"5833_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ymeth.2021.08.001","volume":"198","author":"X-Y Li","year":"2022","unstructured":"Li X-Y et al (2022) NetAUC: a network-based multi-biomarker identification method by AUC optimization. Methods 198:56\u201364","journal-title":"Methods"},{"issue":"1","key":"5833_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62818-3","volume":"16","author":"Y-H Lo","year":"2025","unstructured":"Lo Y-H et al (2025) Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions. Nat Commun 16(1):7566","journal-title":"Nat Commun"},{"issue":"6330","key":"5833_CR51","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord CJ, Ashworth A (2017) PARP inhibitors: the first synthetic lethal targeted therapy. Science (New York, NY) 355(6330):1152","journal-title":"Science (New York, NY)"},{"issue":"3","key":"5833_CR52","first-page":"1136","volume":"9","author":"MH Ma","year":"2003","unstructured":"Ma MH et al (2003) The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents. Clin Cancer Res 9(3):1136\u20131144","journal-title":"Clin Cancer Res"},{"issue":"7","key":"5833_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A et al (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14(7):399\u2013416","journal-title":"Nat Rev Clin Oncol"},{"key":"5833_CR54","doi-asserted-by":"publisher","DOI":"10.2147\/bctt.s348060","author":"M Maqbool","year":"2023","unstructured":"Maqbool M, Bekele F, Fekadu G (2023) Treatment strategies against triple-negative breast cancer: an updated review. Breast Cancer Targets Ther. https:\/\/doi.org\/10.2147\/bctt.s348060","journal-title":"Breast Cancer Targets Ther"},{"issue":"1","key":"5833_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22631-z","volume":"8","author":"K Mohanraj","year":"2018","unstructured":"Mohanraj K et al (2018) IMPPAT: a curated database of Indian medicinal plants, phytochemistry and therapeutics. Sci Rep 8(1):4329","journal-title":"Sci Rep"},{"issue":"7","key":"5833_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072128","volume":"15","author":"AH Morshed","year":"2023","unstructured":"Morshed AH et al (2023) Baicalein as promising anticancer agent: a comprehensive analysis on molecular mechanisms and therapeutic perspectives. Cancers (Basel) 15(7):2128","journal-title":"Cancers (Basel)"},{"issue":"2","key":"5833_CR57","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1093\/pcp\/pcs186","volume":"54","author":"K Nakamura","year":"2013","unstructured":"Nakamura K et al (2013) KNApSAcK-3D: a three-dimensional structure database of plant metabolites. Plant Cell Physiol 54(2):e4\u2013e4","journal-title":"Plant Cell Physiol"},{"issue":"10","key":"5833_CR58","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1038\/cddis.2013.410","volume":"4","author":"P Nigro","year":"2013","unstructured":"Nigro P, Pompilio G, Capogrossi M (2013) Cyclophilin A: a key player for human disease. Cell Death Dis 4(10):e888","journal-title":"Cell Death Dis"},{"key":"5833_CR59","unstructured":"Pag\u00e8s H et al (2017) Package \u2018annotationdbi\u2019. Bioconductor Packag Maint 10 B9"},{"key":"5833_CR60","doi-asserted-by":"crossref","unstructured":"Plinski EF, Plinska S (2020) Veber\u2019s rules in terahertz light","DOI":"10.21203\/rs.2.22281\/v1"},{"key":"5833_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-cancerbio-041916-065808","volume":"1","author":"CR Reczek","year":"2017","unstructured":"Reczek CR, Chandel NS (2017) The two faces of reactive oxygen species in cancer. Annu Rev Cancer Biol 1:79\u201398","journal-title":"Annu Rev Cancer Biol"},{"key":"5833_CR62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/bs.ircmb.2021.04.001","volume":"364","author":"X Renaudin","year":"2021","unstructured":"Renaudin X (2021) Reactive oxygen species and DNA damage response in cancer. Int Rev Cell Mol Biol 364:139\u2013161","journal-title":"Int Rev Cell Mol Biol"},{"issue":"7","key":"5833_CR63","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47\u2013e47","journal-title":"Nucleic Acids Res"},{"key":"5833_CR64","doi-asserted-by":"crossref","unstructured":"Safran M et al (2010) GeneCards Version 3: the human gene integrator. Database 2010:baq020","DOI":"10.1093\/database\/baq020"},{"issue":"1","key":"5833_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbamcr.2013.08.012","volume":"1843","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Finley D (2014) Regulation of proteasome activity in health and disease. Biochimica Et Biophysica Acta (BBA)-Molecular Cell Res 1843(1):13\u201325","journal-title":"Biochimica Et Biophysica Acta (BBA)-Molecular Cell Res"},{"issue":"11","key":"5833_CR66","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.2174\/1570180819666220816115506","volume":"20","author":"MH Shahrajabian","year":"2023","unstructured":"Shahrajabian MH, Sun W (2023) Survey on medicinal plants and herbs in traditional Iranian medicine with anti-oxidant, anti-viral, anti-microbial, and anti-inflammation properties. Lett Drug des Discovery 20(11):1707\u20131743","journal-title":"Lett Drug des Discovery"},{"issue":"11","key":"5833_CR67","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"issue":"D1","key":"5833_CR68","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","volume":"44","author":"D Szklarczyk","year":"2016","unstructured":"Szklarczyk D et al (2016) STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data. Nucleic Acids Res 44(D1):D380\u2013D384","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5833_CR69","doi-asserted-by":"publisher","first-page":"D730","DOI":"10.1093\/nar\/gkae1113","volume":"53","author":"D Szklarczyk","year":"2025","unstructured":"Szklarczyk D et al (2025) The STRING database in 2025: protein networks with directionality of regulation. Nucleic Acids Res 53(D1):D730\u2013D737","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"5833_CR70","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.18632\/oncotarget.3023","volume":"6","author":"L Taliaferro-Smith","year":"2015","unstructured":"Taliaferro-Smith L et al (2015) FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells. Oncotarget 6(7):4757","journal-title":"Oncotarget"},{"issue":"7","key":"5833_CR71","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579\u2013591","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"5833_CR72","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"9","key":"5833_CR73","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/15353702231179961","volume":"248","author":"HS Tuli","year":"2023","unstructured":"Tuli HS et al (2023) Wogonin, as a potent anticancer compound: from chemistry to cellular interactions. Exp Biol Med (Maywood) 248(9):820\u2013828","journal-title":"Exp Biol Med (Maywood)"},{"issue":"17","key":"5833_CR74","first-page":"6316","volume":"9","author":"PM Voorhees","year":"2003","unstructured":"Voorhees PM et al (2003) The proteasome as a target for cancer therapy. Clin Cancer Res 9(17):6316\u20136325","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5833_CR75","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B et al (2023) ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol 97(6):1439\u20131451","journal-title":"Arch Toxicol"},{"issue":"6","key":"5833_CR76","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/antiox14060735","volume":"14","author":"M Wang","year":"2025","unstructured":"Wang M et al (2025) Oxidative stress and inflammation: drivers of tumorigenesis and therapeutic opportunities. Antioxidants (Basel) 14(6):735","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"5833_CR77","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/wics.147","volume":"3","author":"H Wickham","year":"2011","unstructured":"Wickham H (2011) Ggplot2. Wiley Interdiscip Rev Comput Stat 3(2):180\u2013185","journal-title":"Wiley Interdiscip Rev Comput Stat"},{"issue":"5","key":"5833_CR78","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G et al (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J Integr Biol 16(5):284\u2013287","journal-title":"Omics J Integr Biol"},{"issue":"2","key":"5833_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1298","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan S, Chan HS, Hu Z (2017) Using PyMOL as a platform for computational drug design. Wiley Interdiscip Rev Comput Mol Sci 7(2):e1298","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"key":"5833_CR80","doi-asserted-by":"crossref","unstructured":"Zhang Y (2004) Cancer chemoprevention with sulforaphane, a dietary isothiocyanate. Phytochemicals in health and disease. CRC Press, pp 130\u2013149","DOI":"10.1201\/9780203021408-14"},{"key":"5833_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01787","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang J et al (2020) Transcriptome-based network analysis unveils eight immune-related genes as molecular signatures in the immunomodulatory subtype of triple-negative breast cancer. Front Oncol 10:1787","journal-title":"Front Oncol"},{"key":"5833_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1689103","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z et al (2025) Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response. Front Immunol 16:1689103","journal-title":"Front Immunol"},{"issue":"14","key":"5833_CR83","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1111\/febs.16768","volume":"290","author":"L Zhou","year":"2023","unstructured":"Zhou L et al (2023) MAEL facilitates metabolic reprogramming and breast cancer progression by promoting the degradation of citrate synthase and fumarate hydratase via chaperone-mediated autophagy. FEBS J 290(14):3614\u20133628","journal-title":"FEBS J"},{"key":"5833_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119126","volume":"338","author":"J Zhou","year":"2025","unstructured":"Zhou J et al (2025) Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer. J Ethnopharmacol 338:119126","journal-title":"J Ethnopharmacol"},{"key":"5833_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.149128","author":"J Zhu","year":"2025","unstructured":"Zhu J et al (2025) Pan-cancer analysis identifies adhesion G protein-coupled receptor G6 as a potential prognostic and immunotherapeutic biomarker with its functional validation. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149128","journal-title":"Int J Biol Macromol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05833-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05833-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05833-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:50:41Z","timestamp":1787284241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05833-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":85,"alternative-id":["5833"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05833-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}